Cargando…

Tumour markers in breast cancer.

The clinical usefulness of 8 potential tumour markers has been evaluated in 69 patients with Stage I and II breast cancer and 57 patients with Stage III and IV. Serum CEA concentrations were raised in 13% of patients with local and 65% of those with advanced breast cancer. In patients with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cove, D. H., Woods, K. L., Smith, S. C., Burnett, D., Leonard, J., Grieve, R. J., Howell, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1979
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010109/ https://www.ncbi.nlm.nih.gov/pubmed/92331

Ejemplares similares

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Objective measurement of therapeutic response in breast cancer using tumour markers.
por: Robertson, J. F., et al.
Publicado: (1991)

Effect of sodium butyrate on synthesis of specific proteins by human breast-carcinoma cells.
por: Grieve, R. J., et al.
Publicado: (1980)

Mathematical modelling of tumour response in primary breast cancer.
por: Cameron, D. A., et al.
Publicado: (1996)

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.
por: Peters, K. G., et al.
Publicado: (1998)

The Chemical Induction of Breast Tumours in the Rat: Hormonal Factors in Tumour Production
por: Howell, J. S.
Publicado: (1960)

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
por: Dixon, A. R., et al.
Publicado: (1993)

Epidermal and transforming growth factor alpha in patients with breast tumours.
por: Gregory, H., et al.
Publicado: (1989)

Comparative values of several tumour markers: example of untreated breast carcinoma.
por: Cazin, J. L., et al.
Publicado: (1990)

Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980)

Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer
por: Magdalena, C, et al.
Publicado: (2000)

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.
por: Howell, A., et al.
Publicado: (1996)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.
por: Thompson, A. M., et al.
Publicado: (1990)

The value of tumour markers in lung cancer.
por: Gomm, S. A., et al.
Publicado: (1988)

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
por: Shao, R, et al.
Publicado: (2011)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Tumour markers of prognosis in colorectal cancer
por: McLeod, H L, et al.
Publicado: (1999)

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes.
por: Morrison, J. M., et al.
Publicado: (1989)

Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?
por: Redman, C. W., et al.
Publicado: (1990)

The human tumour cloning assay in the management of breast cancer patients.
por: Dittrich, C., et al.
Publicado: (1985)

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.
por: Morrison, J. M., et al.
Publicado: (1989)

Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
por: Cline, J. M., et al.
Publicado: (1990)

99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.
por: Biassoni, L., et al.
Publicado: (1998)

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000
por: Basuyau, J P, et al.
Publicado: (2003)

Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana
por: Atta Manu, E., et al.
Publicado: (2020)

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response
por: Cameron, D A, et al.
Publicado: (2000)

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.
por: Smith, K. A., et al.
Publicado: (1988)

Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
por: Begent, R. H., et al.
Publicado: (1982)

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography
por: Møller, Pål, et al.
Publicado: (2015)

Assessing tumour markers.
por: Tate, H.
Publicado: (1981)

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
por: Wärnberg, F, et al.
Publicado: (2001)

An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
por: Raleigh, J. A., et al.
Publicado: (1994)

Strategies for five tumour markers in the screening and diagnosis of female breast cancer
por: Luo, Jun, et al.
Publicado: (2023)

Case of a Tumour in the Vagina, Mistaken for Placenta Prœvia
por: Grieve, James
Publicado: (1861)

Heterogeneity of O(6)-alkylguanine DNA-alkyltransferase expression in human breast tumours
por: Clemons, M J, et al.
Publicado: (2002)

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
por: Parkes, H. C., et al.
Publicado: (1990)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p1hmk1a9lnhknl84dugu9gujbc